CADAS138 emerges as a novel therapeutic target in the realm of chronic illnesses. Preclinical studies reveal significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers are https://iwanpjpq169642.blog5.net/90360147/a-promising-therapeutic-avenue